ArticleScientific reports2024

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate.

Shenglong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.